First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: Apr 29, 2024

Clarus Therapeutics Holdings Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Operating Income
-$39.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Operating Income
$23.4B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$10.8B
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
-3%
Merck & Co Inc
NYSE:MRK
Operating Income
$4.1B
CAGR 3-Years
-28%
CAGR 5-Years
-19%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Operating Income
$10.3B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
6%

See Also

What is Clarus Therapeutics Holdings Inc's Operating Income?
Operating Income
-39.7m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Operating Income amounts to -39.7m USD.

What is Clarus Therapeutics Holdings Inc's Operating Income growth rate?
Operating Income CAGR 1Y
16%

Over the last year, the Operating Income growth was 16%.